Titrating graft-versus-host disease: is it worth a try?
Open Access
- 25 September 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 38 (10), 653-656
- https://doi.org/10.1038/sj.bmt.1705504
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Graft-versus-Host Reactions and the Effectiveness of Donor Lymphocyte InfusionsTransplantation and Cellular Therapy, 2006
- Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell TransplantationTransplantation, 2006
- Prophylaxis and Treatment of Acute Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myelomaBlood, 2004
- Molecules and mechanisms of the graft-versus-leukaemia effectNature Reviews Cancer, 2004
- Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationBlood, 2003
- Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantationBlood, 2003
- Optimizing engraftment—source and dose of stem cellsSeminars in Hematology, 2002
- Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Graft versus Host Reaction modified by in vitro Marrow–Erythrocyte PreincubationNature, 1969